Get Help Sign In
ProcessingProcessing

American Society of Human Genomics (ASHG) 2022

22_IDT_LP_ASHG-Event-Page

IDT is excited to attend the American Society of Human Genomics annual meeting in Los Angeles.

In March 2021, IDT acquired Swift Biosciences, a move that enhanced our ability to provide a more comprehensive NGS research portfolio. Now, you can uncover a flexible range of NGS solutions designed to help you sequence samples and generate research data you never thought you could.

In addition to our growing NGS portfolio, IDT continues to support researchers with complementary PCR solutions to complete your workflow.

What new NGS technology does IDT offer?

2021 was a big year for the future of IDT’s xGen™ NGS portfolio. In addition to the Swift acquisition, we have new leadership in place and an expanded NGS team. Together, IDT is uniquely positioned to offer:

What new qPCR products does IDT offer?

  • PrimeTime™ One-Step 4X Broad-Range Master Mix: A premium RT-PCR master mix for viral research that gives you the flexibility to perform either extracted or direct amplification
  • Predesigned primer and probe sets for COVID-19, influenza, and monkeypox

What networking can IDT offer?

Our associates will be easy to spot at ASHG—you’ll find us wearing blue shirts!

Want to learn firsthand about the exciting products xGen NGS has to offer? Sign up for a one-on-one with an IDT expert while you’re at ASHG:

Throughout the ASHG event, you can also:

  • Take a coffee break with IDT’s leadership and team members at Booth 1149 and explore what the expanded xGen NGS and qPCR portfolios can do for you
  • Learn more about the applications of xGen NGS solutions from IDT’s strategic marketing manager and our guest collaborator from Geneseeq

From bench to breakthrough. We’ll help.

Speakers

To learn more, stop by Booth 1149 and attend the CoLab Session with Geneseeq Technologies

Date: October 26, 2022 | 3:00-3:30 p.m.
Presented by: Hai Meng Tang, Geneseeq Technologies Bioinformatician
Title: ctDNA for minimal residual disease research by hybridization capture in resected cancer samples

Event information

Date:

October 25-October 29, 2022

Location:

Los Angeles, California, USA

Visit us at booth 1149